Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor textual updates to the Publications section clarify that PubMed entries are automatically filled and may not all be related to the study. The page revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe banner containing the government funding operating-status disclaimer was removed from the page. The study details and related information remain unchanged.SummaryDifference0.4%

- Check35 days agoChange DetectedThe study results have been posted to the study record (Results First Posted 2025-07-31). This update adds results-related information and references to publications.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.SummaryDifference3%

- Check71 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.